期刊文献+

组织工程心脏瓣膜研究进展(综述) 被引量:1

Progress in Heart Valve Tissue-engineered Research
下载PDF
导出
摘要 心脏瓣膜置换术是外科治疗瓣膜性心脏病的主要方法,临床应用的人工心脏瓣膜存在着需要终身抗凝或瓣膜容易衰败等缺点。随着组织工程学的发展,心脏瓣膜方面的研究已取得初步进展。该文综述近年来组织工程心脏瓣膜在种植材料、种子细胞、动物实验和基础研究方面取得的进展,并探讨组织工程心脏瓣膜的优越性和可行性。 Heart valve replacement is the main method to treat the valvular heart disease.There is the need for lifelong anticoagulation or valvular defects easy to decay and so on.With the development of tissue engineering,the studies on heart valve tissue engineering have made progresses in there fields:scaffold materials,seeded cells and the construction.Recent study consists of three main aspects:selecting and manufacturing of scaffold materials,seed cell selecting and seeding and culturing of seed cells.Tissue engineering heart valve,which may overcome the shortages of biological and mechanical prosthetic valves,has a widely developing future.
出处 《安徽卫生职业技术学院学报》 2009年第6期79-80,共2页 Journal of Anhui Health Vocational & Technical College
关键词 组织工程 心脏瓣膜 生物材料 tissue engineering heart valve biological materials
  • 相关文献

参考文献13

  • 1Vesely I. Heart valve tissue engineering [J]. Circ Res 2005, 97(8):743-755.
  • 2Knight RL,Wilcox HE,Korossis SA,et al.The use of acellular matrices for the tissue engineering of cardiac valves [J].Proc Inst Mech Eng. 2008, 222 (1): 129-143.
  • 3Mirensky TL, Breuer CK.The development of tissue-engineered grafts for reconstructive cardiothoracic surgical applications.Pediatr Res.2008,63(5):559-568.
  • 4Steinhoff G, Stock U, Karim N, et al. Tissue engineering of pulmonary heart valves on allogenic acellular matrix conduits: in vivo restoration of valve tissue [J]. Circulation. 2000, 102(19):50-55.
  • 5Gilbert TW,Sellaro TL,Badylak SF. Decellularization of tissues and organs. Biomaterials. 2006, 27 (19): 3675-3683.
  • 6Farhat WA, Chen J, Haig J, et al. Porcine bladder acellular matrix (ACM): protein expression, mechanicaI properties. Biomed Mater. 2008, 3(2): 25015.
  • 7Lichtenberg A, Tudorache I, Cebotari S, et al. Preclinical testing of tissue-engineered heart valves re- endothelialized under simulated physiological conditions [J]. Circulation. 2006, 114(1 Suppl): 1559-565.
  • 8Vincentlli A,Wautot F,Juthier F,et al. In vivo autologous recellularization of a tissue-engineered heart valve:Are bone marrow mesenchymal stem ceils the best eandidates[J].J Thorac Cardiovasc Surg,2007, 134 (2): 424-432.
  • 9Vincentelli A, Wautot F, Juthier F, et al. In vivo autologous recellularization of a tissue-engineered heart valve: are bone marrow mesenchymal stem cells the best candidates [J]. J Thorac Cardiovasc Surg. 2007, 134(2):424-432.
  • 10Perry TE, Kaushal S, Sutherland FW, Guleserian K J, Bischoff J, Sacks M, Mayer JE. Thoracic Surgery Directors Association Award. Bone marrow as a cell source for tissue engineering heart valves [J]. Ann Thorac Surg, 2003, 75:761-767.

二级参考文献26

  • 1Kadner A, Hoerstrup SP, Tracy J, et al. Human umbilical cord cells: a new cell source for cardiovascular tissue engineering. Ann Thorac Surg,2002 Oct;74(4) :S1422 - 8.
  • 2Schmidt D, Mol A, Breymann C, et al. Living autologous heart valves engineered from human prenatally harvested progenitors. Circulation, 2006 Jul 4; 114(1 Suppl) :I125 - 31.
  • 3Veinot JP, Prichett - Pejic W, Song J, et al. CD117- positive cells and mast cells in adult human cardiac valves-observations and implications for the creation of bioengineered grafts. Cardiovasc Pathol, 2006 Jan - Feb; 15 (1): 36 - 40.
  • 4Wiester LM, Giachelli CM. Expression and function of the integrin alpha9betal in bovine aortic valve interstitial cells. J Heart Valve Dis, 2003 Sep; 12(5):605- 16.
  • 5Masters KS, Shah DN, Walker G, et al. Designing scaffolds for valvular interstitial cells: cell adhesion and function on naturally derived materials. J Biomed Mater Res A,2004 Oct 1 ;71(1) : 172 - 80.
  • 6Dumont K, Yperman J, Verbeken E, et al. Design of a new pulsatile bioreactor for tissue engineered aortic heart valve formation. Artif Organs, 2002 Aug;26(8) :710 - 4.
  • 7Gulbins H, Pritisanac A, Petzold R, et al. A low- flow adaptation phase improves shear- stress resistance of artificially seeded endothelial cells. Thorac Cardiovasc Surg, 2005 Apr; 53 (2) : 96 - 102.
  • 8Stock UA, Nagashima M, Khalil PN, et al. Tissue -engineered valved conduits in the pulmonary circulation. J Thorac Cardiovasc Surg, 2000 Apr; 119 (4 Pt 1):732-40.
  • 9Shinoka T. Tissue engineered heart valves: autologous cell seeding on biodegradable polymer scaffold. Artif Organs,2002 May;26(5) :402 - 6.
  • 10Kim WG, Lee WY, Mi Kim J. Tissue- engineered acellularized valve xenografts: a comparative animal study between plain acellularized xenografts and autologous endothelial cell seeded acellularized xenografts. Int J Artif Organs, 2004 Jun; 27 ( 6 ) : 501 - 8.

同被引文献6

引证文献1

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部